Factor V Leiden improves in vivo hemostasis in murine hemophilia models (Q33229687)

24 July 2017

title

Factor V Leiden improves in vivo hemostasis in murine hemophilia models (English)

1 reference

24 July 2017

0 references

1 reference

Schlachterman A

1

1 reference

24 July 2017

Schuettrumpf J

2

1 reference

24 July 2017

Liu JH

3

1 reference

24 July 2017

Furlan Freguia C

4

1 reference

24 July 2017

Toso R

5

1 reference

24 July 2017

Poncz M

6

1 reference

24 July 2017

Camire RM

7

1 reference

24 July 2017

Arruda VR

8

1 reference

24 July 2017

publication date

1 December 2005

1 reference

Journal of Thrombosis and Haemostasis

24 July 2017

published in

1 reference

24 July 2017

volume

3

1 reference

24 July 2017

issue

12

1 reference

24 July 2017

page(s)

2730-2737

1 reference

Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. The French Study Group. secretariat.haemophiles@cch.ap-hop-paris.fr

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01639.X

Factor V: a combination of Dr Jekyll and Mr Hyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01639.X

Mutation in blood coagulation factor V associated with resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01639.X

Does activated protein C-resistant factor V contribute to thrombin generation in hemophilic plasma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01639.X

Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01639.X

Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01639.X

Factor IX variants improve gene therapy efficacy for hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01639.X

Removal of B-domain sequences from factor V rather than specific proteolysis underlies the mechanism by which cofactor function is realized

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01639.X

Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01639.X

The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01639.X

Recombinant murine-activated protein C is neuroprotective in a murine ischemic stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01639.X

Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01639.X

21 January 2018

The Protein C Pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01639.X

10.1111/J.1538-7836.2005.01639.X

21 January 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference